Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Best MK-677 Dosage for Recovery: Comparison

10–12.5mg daily 40–50% over baseline 45–65% increase Sleep enhancement, minor soft tissue recovery, collagen synthesis support Minimal. Mild appetite increase, transient water retention in 15% of users Optimal for long-term protocols (16+ weeks) where sustaina

This comparison does not assign a generated winner or score.

  • 10–12.5mg daily
  • 40–50% over baseline
  • 45–65% increase
  • Sleep enhancement, minor soft tissue recovery, collagen synthesis support
  • Minimal. Mild appetite increase, transient water retention in 15% of users
  • Optimal for long-term protocols (16+ weeks) where sustainability and side effect minimisation are priorities
  • 15–20mg daily
  • 60–75% over baseline
  • 55–90% increase
  • Muscle preservation during deficit, injury recovery, nitrogen retention during immobilisation
  • Moderate. Water retention in 25–30%, fasting glucose elevation 5–8%, increased appetite
  • Sweet spot for most recovery applications. Balances efficacy with tolerability across 8–16 week protocols
  • 20–25mg daily
  • 85–97% over baseline
  • 90–120% increase
  • Acute injury rehabilitation, post-surgical recovery, severe muscle wasting
  • Significant. Water retention 35–45%, fasting glucose elevation 8–12%, insulin resistance markers in extended use
  • Reserve for short-duration high-demand scenarios (8 weeks maximum). Diminishing returns versus mid-range dosing
More references

Related material